Honda will test a new Kalex chassis prior to April’s Americas GP, as it goes into the 2023 MotoGP season on the backfoot 🧪 Full story ⬇️
Honda is set to test a new chassis designed by Kalex prior to April’s Americas Grand Prix as it heads into the 2023 MotoGP season on the backfoot.The Japanese manufacturer has endured a tough 12 months as it suffered its second winless campaign in three years, and is coming into the 2023 campaign – which starts this weekend in Portugal – off the back of a tough pre-season.
As part of numerous major changes within Honda in a bid to overturn the slide it has suffered, Honda has been working with German chassis manufacturer Kalex in recent months.This first manifested itself in the form of a swingarm, which was used in the back half of last season. But the frame will now be tested by Stefan Bradl and the HRC test team helmed by crew chief Ramon Aurin and new technical director Ken Kawauchi at Jerez in a private outing on 4-6 April.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
NASCAR 2023 COTA schedule, entry list, and how to watchTwo former F1 World Champions, a future NASCAR Hall of Famer, an IMSA star and IndyCar driver are among those joining the field for this weekend's Cup race at COTA. Everything you need to know ahead of this highly anticipated race weekend:
Read more »
The Americas face a historic opportunity. Will the region grasp it?As the United States pulls away from China, it needs its neighbours more than ever
Read more »
Raikkonen “excited” to return to NASCAR Cup racing at COTAKimi Raikkonen says he\u2019s \u201cexcited\u201d to return to NASCAR Cup competition this weekend at Austin\u2019s Circuit of the Americas, where he will race against fellow Formula 1 world champion Jenson Button.
Read more »
Raikkonen “excited” to return to NASCAR Cup racing at COTAKimi Raikkonen says he\u2019s \u201cexcited\u201d to return to NASCAR Cup competition this weekend at Austin\u2019s Circuit of the Americas, where he will race against fellow Formula 1 world champion Jenson Button.
Read more »
Prior COVID and vaccination generate superior hybrid immunityIn a recent article published in the journal Science Translational Medicine, researchers in France performed a long-term longitudinal analysis to demonstrate the benefits of hybrid immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), i.e., induced by viral infection followed by vaccination.
Read more »
Prevalence and correlates of prescription opioid use among US adults, 2019–2020This study estimates the prevalence of prescription opioid use (POU) in the United States (US) in 2019–2020, both in the general population and specifically among adults with pain. It also identifies key geographic, demographic, and socioeconomic correlates of POU. Data were from the nationally-representative National Health Interview Survey 2019 and 2020 (N=52,617). We estimated POU prevalence in the prior 12 months among all adults (18+), adults with chronic pain (CP), and adults with high-impact chronic pain (HICP). Modified Poisson regression models estimated POU patterns across covariates. We found POU prevalence of 11.9% (95% CI 11.5, 12.3) in the general population, 29.3% (95% CI 28.2, 30.4) among those with CP, and 41.2% (95% CI 39.2, 43.2) among those with HICP. Findings from fully-adjusted models include the following: In the general population, POU prevalence declined about 9% from 2019 to 2020 (PR=0.91, 95% CI 0.85, 0.96). POU varied substantially across US geographic regions: It was significantly more common in the Midwest, West, and especially the South, where adults had 40% higher POU (PR=1.40, 95% CI 1.26, 1.55) than in the Northeast. In contrast, there were no differences by rural/urban residence. In terms of individual characteristics, POU was lowest among immigrants and among the uninsured, and was highest among adults who were food insecure and/or not employed. These findings suggest that prescription opioid use remains high among American adults, especially those with pain. Geographic patterns suggest systemic differences in therapeutic regimes across regions but not rurality, while patterns across social characteristics highlight the complex, opposing effects of limited access to care and socioeconomic precarity. Against the backdrop of continuing debates about benefits and risks of opioid analgesics, this study identifies and invites further research about geographic regions and social groups with particularly high or low prescription opioid u
Read more »